CHAPPAQUA, N.Y. (PRWEB) March 20, 2019
Many companies are developing anti-aging drugs using telomerase activation, but Nanorx Inc is paving the way for safe clinical testing.
A recent publication in the Journal of Stem Cell Research & Therapy featured Metadichol®, an immune system booster developed by Nanorx Inc. that has shown promising results for the reversal of aging. The paper, entitled “Quest for Immortality Introducing Metadichol®, a Novel Telomerase Activator,” was published on March 5, 2019. The article describes the effect of Metadichol ® on telomerase expression profile on umbilical cord cells. It shows the optimistic research being performed on age reversal.
“As a long term user of Metadichol® for over 5 years, I have seen a 24 percent decrease in my biological age based on measurement of the telomeres length,” said Dr. P.R. Raghavan, Chairman, and CEO of Nanorx, Inc. “We have also seen positive changes in other long term users. Use of telomerase to reverse aging is promising and exciting, and we believe Metadichol® could pave the way for this new age.”
Public research suggests that telomerase, an enzyme that is found in the cell, is the key to the reversal of aging. Cell division is necessary for the making of new cells. Every time cells divide, they must duplicate their DNA, and telomerase adds repetitive caps called telomeres to the strand. With each division, a portion of the telomeres is shortened, which leads to age-related cellular breakdown. Without telomeres, chromosome ends may fuse and corrupt the cell's genetic blueprint, possibly causing malfunction, cancer, or cell death. Many companies are performing research to prevent telomeres shortening or to lengthen telomeres artificially.
Some companies have developed a procedure to deliver telomerase to cells with the insertion of modified viruses that carry the telomerase gene. This is complicated in practice, as gene therapy has adverse effects, and no human trials are known that express the ability to deliver telomerase effectively to human cells. Metadichol and its expression of telomerase delivery in-vivo to the blood overcomes the hurdles facing researchers in the field.
Metadichol® is an extract from food-based sources and is devoid of toxic effects, and it can be directly tested on humans. It is currently available in an easily absorbable emulsion with the name Metadichol and Nano-Ojas. Metadichol strengthens the immune system and restores balance to other vital functions including wound healing, stimulating cell regeneration and promoting healthy energy levels. Metadichol® acts on the vitamin D nuclear receptors of each cell like an active vitamin D and thus regulates up to 700+ genes of vital importance for the cellular life. Metadichol® paves the way for safe clinical testing and research of telomerase biology and provides enormous medical and financial benefits due to its use in fighting human diseases and reducing the rate of aging.
Nanorx Inc, has published many research papers on the effectiveness of Metadichol® in treating age-related diseases including the expression of Klotho, an anti-aging gene, and the inhibition of the BCAT1 gene, which is implicated in the aging process. The paper in the Journal of Stem Cell Research & Therapy showed that using q-RT-PCR techniques telomerase mRNA gene h-Tert expression showed a sixteen-fold increase at one picogram per ml concentration. Western blot studies showed the expression of Telomerase protein is being maintained at a replacement level. Aging is a law of nature and unavoidable. Instead of targeting a multitude of diseases that confront us as we age Metadichol is about correcting the root cause of diseases as exemplified by our patents and publications. Reversing aging is becoming more attainable, and the future is bright with Metadichol®. Ongoing research and work profiling of other long term users will be reported in an upcoming international conference later this year. The article on Metadichol® and how it potentially reverse signs of aging can be found at http://www.researchgate.net,. Or at http://www.academia.edu.
For licensing and marketing opportunities, contact Dr. P.R. Raghavan at raghavan(at)nanorxinc.com.
Nanorx a privately owned company founded in 2008 in New York that has developed a plant-based nano-emulsion of long-chain aliphatic alcohols, which improves the immune system and balances other vital functions. Metadichol® is covered by US patents and has been granted patents in many other countries. Visit https://www.nanoojas.net/ and http://www.gen100.com to view the company's products.